Tissue Engineered Skin Substitutes Market Size & Growth Analysis

The global market size for Tissue Engineered Skin Substitutes Market was estimated at USD 658.2 million in 2022 and is projected to rise at CAGR of 4.5% during forecast period 2023 - 2030. Growing incidences of skin disorders owing to burn injuries and increasing incidences of vascular diseases will drive the demand for the Tissue Engineered Skin Substitutes market growth.

Tissue engineering is a technique for the restoration, maintenance and improvement of damaged tissues and organs. It develops functional tissues, using a combination of scaffolds, biologically active molecules, and cells as an alternative to natural ones. The skin replacements are developed using human or non-human tissue, or a combination of both. 

Production for tissue-engineered skin replacements is increasing as a result of advances in healthcare technology, increased prevalence of acute and chronic wounds, intense competition for skin grafts and increased awareness of various treatment options. Increasing instances of obesity and diabetes and growth of the elderly population are the major factors driving the growth of Tissue Engineered Skin Substitutes Market.

TISSUE ENGINEERED SKIN SUBSTITUTES MARKET REPORT COVERAGE

Segmentation Analysis

This global report on tissue engineered skin substitutes market is segmented and sub-segmented into the following categories:

Tissue Engineered Skin Substitutes Market - By Duration

• Permanent

• Semi-Permanent

Tissue Engineered Skin Substitutes Market - By Anatomical Structure

• Dermal

• Epidermal

• Bi-layered Skin Substitutes/Composite

Tissue Engineered Skin Substitutes Market - By Source

• Acellular

• Cellular Allogeneic

• Cellular Autologus

• Others

Tissue Engineered Skin Substitutes Market - By Material

• Synthetic

  • Biodegradable

  • Non-Biodegradable

• Biosynthetic

• Biological

Biological tissue engineered skin replacements segment held the largest market share owing to the increasing prevalence of acute wounds globally. The major advantage of skin substitutes that are engineered for biological tissue is that skin is readily available from the patient itself. Biological tissue-engineered skin replacements have more extracellular matrix, which helps excellent re-epithelialisation and faster healing of the wound. The synthetic tissue engineered skin substitute segment is anticipated to witness the fastest growth. Synthetic tissue engineered skin substitutes demonstrate more control over scaffold composition.

Tissue Engineered Skin Substitutes Market - By Technology

• Laser assisted bio printing

• 3D

• Robotic Technology

• Others

Tissue Engineered Skin Substitutes Market - By Application

• Chronic Wounds

• Burn Cases/Burn Injury

• Traumatic Wounds

• Diabetic/Vascular Wounds

• Others

Tissue Engineered Skin Substitutes Market - By End User

• Hospitals

  • Super-Specialty hospitals

  • Multi-Specialty Hospitals

• Other Facilities

Rapid increase in the number of surgeries around the globe, the hospital segment held the largest revenue share in the tissue engineered skin replacements market. The large key drivers for the segment are the increasing cases of diabetic foot ulcers and venous leg ulcers is driving increasing cases of surgical wounds owing to an increasing number of surgeries. Increasing awareness among people about different treatment options is also a key driving factor in the market The market is also gaining pace owing to people's increasing willingness to spend more and opt for new and advanced burn care products.

Tissue Engineered Skin Substitutes Market - By Geography

• North America

• Europe

• Asia Pacific

• Rest of the World

North American tissue-engineered skin replacement market held the largest revenue share in 2022 owing to technological advances in the healthcare sector, an increasing number of burn injuries and the presence of key players in the region. Increasing injuries from sports, road accidents and the presence of several key players in the region are anticipated to propel the market.

Asia Pacific tissue-engineered skin replacement market is anticipated to witness the fastest growth rate over the forecast period. The presence of developing countries such as China, India and Japan is projected to increase the region's market growth. The rapidly growing medical tourism industry in these countries can also be attributed to the region's increasing demand for tissue-engineered skin replacements.

Key Market Players

The Key players operating the Tissue Engineered Market are Amarantus BioScience Holdings, Organogenesis, KCI Licensing, Acelity L.P. Inc., Smith & Nephew Plc, and Integra Life Sciences Holdings Corporation, 3M Inc., BSN Medical GmbH, Convatec Group Plc, Molnlycke Healthcare AB and others.